文献速递流行病学与生物统计临床试验与 GCP

老年人听力损失筛查:美国预防服务工作组更新证据报告与系统综述

Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
PubMed 文献 · JAMA · 2021-01-01

单问题筛查对轻度听力损失的合并敏感度为66%,特异度为76%;对中度听力损失的合并敏感度为80%,特异度为74%。一项退伍军人试验未发现筛查组与未筛查组在1年听力相关功能上存在显著差异,且无研究报告筛查或干预的危害。

要点

  • 单问题筛查可 adequate 检测老年人听力损失,对中度损失敏感度更高。
  • 筛查获益的随机试验仅纳入退伍军人,未显示1年功能显著改善。
  • 无研究报道筛查或干预的危害,证据存在空白。

核心结论

  • 多种筛查测试可充分检测老年人听力损失,但无研究报告筛查或治疗的危害。
  • 听力 aids 对筛查发现或新发现听力损失成人听力相关功能的获益证据仅限于退伍军人研究。

研究设计与样本

  • 检索MEDLINE、Cochrane Library、EMBASE和试验注册库至2020年1月17日,文献监测至2020年10月8日。
  • 纳入评估筛查测试准确性、筛查或干预的英文研究,双重审查并合并准确性研究。

主要发现

  • 一项美国退伍军人试验(n=2305)评估筛查获益,1年听力相关功能最小临床重要差异比例在筛查组为36%-40%,未筛查组为36%,无显著差异。
  • 单问题筛查检测中度听力损失(>35-40 dB)合并敏感度80%(95% CI 68%-88%),特异度74%(95% CI 59%-85%)(6项研究,n=8774)。
  • 听力障碍老年人筛查量表检测中度听力损失(>40 dB)的5项研究(n=2820)合并敏感度68%(95% CI 52%-81%),特异度78%(95% CI 67%-86%)。
  • 6项试验(n=853)评估放大装置与对照,5项测量听力相关功能,仅3项纳入退伍军人(n=684)的研究发现代表最小重要差异的显著差异(>18.7分)。

关键数值与推荐

  • 单问题筛查检测轻度听力损失(>20-25 dB):敏感度66%(95% CI 58%-73%),特异度76%(95% CI 68%-83%)。
  • 单问题筛查检测中度听力损失(>35-40 dB):敏感度80%(95% CI 68%-88%),特异度74%(95% CI 59%-85%)。
  • 听力障碍老年人筛查量表检测中度听力损失(>40 dB):敏感度68%(95% CI 52%-81%),特异度78%(95% CI 67%-86%)。
  • 放大装置试验中,仅退伍军人研究(n=684)显示听力相关功能最小重要差异(>18.7分)。

临床怎么用

  • 单问题筛查可作为老年人听力损失的初步检测工具,尤其对中度损失敏感度较高。
  • 筛查发现或新发现听力损失后,听力 aids 的获益证据有限,主要来自退伍军人人群。
  • 需告知患者筛查和干预的危害证据缺乏,决策应结合个体情况。

局限性

  • 仅一项试验评估筛查获益,且仅纳入美国退伍军人,外推性受限。
  • 无研究报告筛查或干预的危害。
  • 评估放大装置获益的试验较少,且仅退伍军人研究显示显著差异。
  • 其他合格结局的报告试验有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hearing loss is common in older adults and associated with adverse health and social outcomes. OBJECTIVE: To update the evidence review on screening for hearing loss in adults 50 years or older to inform the US Preventive Services Task Force. DATA SOURCES: MEDLINE, Cochrane Library, EMBASE, and trial registries through January 17, 2020; references; and experts; literature surveillance through October 8, 2020. STUDY SELECTION: English-language studies of accuracy, screening, and interventions for screen-detected or newly detected hearing loss. DATA EXTRACTION AND SYNTHESIS: Dual review of abstracts, full-text articles, and study quality. Meta-analysis of screening test accuracy studies. MAIN OUTCOMES AND MEASURES: Quality of life and function, other health and social outcomes, test accuracy, and harms. RESULTS: Forty-one studies (N = 26 386) were included, 18 of which were new since the previous review. One trial enrolling US veterans (n = 2305) assessed the benefits of screening; there was no significant difference in the proportion of participants experiencing a minimum clinically important difference in hearing-related function at 1 year (36%-40% in the screened groups vs 36% in the nonscreened group). Thirty-four studies (n = 23 228) evaluated test accuracy. For detecting mild hearing loss (>20-25 dB), single-question screening had a pooled sensitivity of 66% (95% CI, 58%-73%) and a pooled specificity of 76% (95% CI, 68%-83%) (10 studies, n = 12 637); for detecting moderate hearing loss (>35-40 dB), pooled sensitivity was 80% (95% CI, 68%-88%) and pooled specificity was 74% (95% CI, 59%-85%) (6 studies, n = 8774). In 5 studies (n = 2820) on the Hearing Handicap Inventory for the Elderly-Screening to detect moderate hearing loss (>40 dB), pooled sensitivity was 68% (95% CI, 52%-81%) and pooled specificity was 78% (95% CI, 67%-86%). Six trials (n = 853) evaluated amplification vs control in populations with screen-detected or recently detected hearing loss over 6 weeks to 4 months. Five measured hearing-related function via the Hearing Handicap Inventory for the Elderly; only 3 that enrolled veterans (n = 684) found a significant difference considered to represent a minimal important difference (>18.7 points). Few trials reported on other eligible outcomes, and no studies reported on harms of screening or interventions. CONCLUSIONS AND RELEVANCE: Several screening tests can adequately detect hearing loss in older adults; no studies reported on the harms of screening or treatment. Evidence showing benefit from hearing aids on hearing-related function among adults with screen-detected or newly detected hearing loss is limited to studies enrolling veterans.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Feltner C, Wallace IF, Kistler CE, et al. Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021. PMID: 33755082. doi:10.1001/jama.2020.24855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。